Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention

(2017) Matthew C. Weiss et al.   Journal of Clinical Lipidology

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

(2017) Pablo Lázaro et al.   Journal of Clinical Lipidology

The renaissance of lipoprotein(a): Brave new world for preventive cardiology?

(2017) Katrina L. Ellis et al.   PROGRESS IN LIPID RESEARCH

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

(2016) Sofie Aagaard Rerup et al.   AMERICAN HEART JOURNAL

Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins

(2016) Loukianos S. Rallidis et al.   ATHEROSCLEROSIS

PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia

(2016) Rodrigo Alonso et al.   ATHEROSCLEROSIS

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   ATHEROSCLEROSIS

Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesClinical Perspective

(2016) David Nanchen et al.   CIRCULATION

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia PhenotypeClinical Perspective

(2016) Amanda M. Perak et al.   CIRCULATION

Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization

(2016) Barak Zafrir et al.   Journal of Clinical Lipidology

Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation

(2016) Martin Bødtker Mortensen et al.   Journal of Clinical Lipidology

Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study

(2016) Sha Li et al.   Journal of Clinical Lipidology

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

(2016) Amit V. Khera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

(2016) Nicholas J Viney et al.   LANCET

Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism

(2016) Katrina L. Ellis et al.   Nature Reviews Endocrinology

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

(2016) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

(2016) Anne Langsted et al.   Lancet Diabetes & Endocrinology

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales

(2015) K. Haralambos et al.   ATHEROSCLEROSIS

Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia

(2015) Dick C. Chan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

(2015) Jing Pang et al.   Journal of Clinical Lipidology

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

(2015) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

(2015) Sotirios Tsimikas et al.   LANCET

Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia

(2014) Zanfina Ademi et al.   Journal of Clinical Lipidology

Lipoprotein(a) Levels in Familial Hypercholesterolemia

(2014) Rodrigo Alonso et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Lipoprotein(a)-cholesterol: A significant component of serum cholesterol

(2011) Kiyoko Kinpara et al.   CLINICA CHIMICA ACTA

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

(2010) Donald M. Lloyd-Jones et al.   CIRCULATION

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

(2009) Robert Clarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population

(2007) Pia R. Kamstrup et al.   CIRCULATION